COLL vs ENPH · P/E 17, rev $181.9M vs P/E 56, rev $1.47B
Collegium Pharmaceutical Inc (COLL) versus Enphase Energy Inc (ENPH) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Enphase Energy Inc (ENPH) is a solar company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ENPH revenue for 2025-12-31 was $1.47B. Net income was $172.1M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
Not investment advice. Open the COLL and ENPH stock pages for the full models.
Not investment advice.